Head of Investor Relations
Johnson & Johnson (JNJ)Equibles does not estimate personal net worth.
Get an email with a short summary when Johnson & Johnson publishes a filing, an earnings call transcript or a press release.
Get JNJ alertsJessica Moore is recorded as Head of Investor Relations at Johnson & Johnson (JNJ). Jessica Moore has spoken on 14 earnings calls and 1 other investor event across 1 company, most recently for Johnson & Johnson on May 19, 2026. Johnson & Johnson is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Johnson & Johnson includes J. Wolk (CFO), D. E. Pinto (Board Member), Daniel Pinto (Board Member) and 7 others.
“So maybe we'll dive into the EP market because that's definitely the hot topic here. I think you've described the global market as a $16 billion opportunity growing about 12%, 13%.”
“The company's review of business results for the fourth quarter and full year 2025, and our financial outlook for 2026. First, a few logistics.”
“Welcome to our company's review of business results for the first quarter of 2025 and our updated financial outlook. A few logistics before we get into the details.”
“Welcome to our company's review of business results for the fourth quarter and full year 2024 and our financial outlook for 2025. A few logistics before we get into the details.”
“Welcome to our company's review of the third quarter results and our full year financial outlook for 2024. A few logistics before we get into the details.”
Drug Manufacturers - General · Healthcare
Head of Investor Relations
